ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Brown Named Dean At Wisconsin, Carnone To Head Cancer Center With Rusch Retirement

June 30, 1978

Public Should Be Warned About Smokeless tobacco Risks, Panel Says

January 24, 1986

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

Roswell Park’s Future “Bright” As Center Snares Leading Scientists, Hohn Says.

January 18, 2002

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979